Please try another search
PARIS - Sanofi (NASDAQ:SNY), a global biopharmaceutical company, announced today a significant investment of over €1 billion to expand its biomanufacturing capabilities in France. This initiative...
PARIS - Sanofi (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting April 1,...
PARIS - Sanofi (NASDAQ:SNY), the French multinational pharmaceutical company, reported a solid performance for the fourth quarter of 2023, with a 9.3% growth in sales at constant exchange rates...
WORLDWIDE – The global initial public offering (IPO) market is poised for a resurgence in 2024, as companies across various regions gear up for significant listings. In Asia, Alibaba (NYSE:BABA)'s...
PARIS - UBS has maintained its neutral stance on the pharmaceutical company Sanofi (NASDAQ:SNY), setting a target price of €100. This valuation reflects the company's confidence in its drug...
Investing.com - European stock markets traded in a mixed fashion Friday, as investors digested a week of corporate earnings, important central bank decisions and economic data. At 03:55 ET (07:55...
By Scott Kanowsky Investing.com -- Shares in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rose on Friday after the drugmaker posted better-than-expected earnings in the fourth quarter despite a dip in...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review